These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1735680)

  • 1. Magnetic resonance spectroscopy studies on experimental murine and human tumors: comparison of changes in phosphorus metabolism with induced changes in vascular volume.
    Adams GE; Bremner JC; Counsell CJ; Stratford IJ; Thomas C; Wood PJ
    Int J Radiat Oncol Biol Phys; 1992; 22(3):467-71. PubMed ID: 1735680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of fluorine-19 nuclear magnetic resonance spectroscopy and hydralazine for measuring dynamic changes in blood perfusion volume in tumors in mice.
    Thomas C; Counsell C; Wood P; Adams GE
    J Natl Cancer Inst; 1992 Feb; 84(3):174-80. PubMed ID: 1542128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of fluorine-19 nuclear resonance spectroscopy for the measurement of changes induced in blood perfusion volume in experimental tumors in vivo].
    Thomas C; Counsell C; Wood P; Adams G
    Bull Cancer; 1993 Aug; 80(8):666-73. PubMed ID: 7515732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo 31P nuclear magnetic resonance spectroscopy of experimental murine tumours and human tumour xenografts: effects of blood flow modification.
    Bremner JC; Counsell CJ; Adams GE; Stratford IJ; Wood PJ; Dunn JF; Radda GK
    Br J Cancer; 1991 Nov; 64(5):862-6. PubMed ID: 1931606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The response of spontaneous and transplantable murine tumors to vasoactive agents measured by 31P magnetic resonance spectroscopy.
    Wood PJ; Stratford IJ; Sansom JM; Cattanach BM; Quinney RM; Adams GE
    Int J Radiat Oncol Biol Phys; 1992; 22(3):473-6. PubMed ID: 1735681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxia.
    Aboagye EO; Maxwell RJ; Kelson AB; Tracy M; Lewis AD; Graham MA; Horsman MR; Griffiths JR; Workman P
    Cancer Res; 1997 Aug; 57(15):3314-8. PubMed ID: 9242466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The measurement of radiosensitizer-induced changes in mouse tumor metabolism by 31P magnetic resonance spectroscopy.
    Wood PJ; Counsell CJ; Bremner JC; Horsman MR; Adams GE
    Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):291-4. PubMed ID: 1825081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of tumour hypoxia by a vasoactive agent. A combined NMR and radiobiological study.
    Dunn JF; Frostick S; Adams GE; Stratford IJ; Howells N; Hogan G; Radda GK
    FEBS Lett; 1989 Jun; 249(2):343-7. PubMed ID: 2737292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative change in blood volume following administration of hydralazine as monitored by 19F NMR spectroscopy.
    Thomas C; Counsell CJ; Wood P; Adams GE
    Int J Radiat Biol; 1991; 60(1-2):219-23. PubMed ID: 1677974
    [No Abstract]   [Full Text] [Related]  

  • 10. Determination of changes in tumor blood perfusion after hydralazine treatment by dynamic paramagnetic-enhanced magnetic resonance imaging.
    Belfi CA; Ting LL; Hassenbusch SJ; Tefft M; Ngo FQ
    Int J Radiat Oncol Biol Phys; 1992; 22(3):477-82. PubMed ID: 1735682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hydralazine administration on oxygenation in spontaneous and transplanted tumor models.
    Fenton BM
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):799-808. PubMed ID: 11172963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The energy metabolism of RIF-1 tumours following hydralazine.
    Bhujwalla ZM; Tozer GM; Field SB; Maxwell RJ; Griffiths JR
    Radiother Oncol; 1990 Nov; 19(3):281-91. PubMed ID: 2281156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 31P MRS of tumour metabolism in anaesthetized vs conscious mice.
    Sansom JM; Wood PJ
    NMR Biomed; 1994 Jun; 7(4):167-71. PubMed ID: 7946994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hydralazine in spontaneous tumours assessed by oxygen electrodes and 31P-magnetic resonance spectroscopy.
    Nordsmark M; Maxwell RJ; Wood PJ; Stratford IJ; Adams GE; Overgaard J; Horsman MR
    Br J Cancer Suppl; 1996 Jul; 27():S232-5. PubMed ID: 8763887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combined measurement of blood flow and metabolism in RIF-1 tumours in vivo. A study using H2 flow and 31P NMR spectroscopy.
    Bhujwalla ZM; Tozer GM; Field SB; Proctor E; Busza A; Williams SR
    NMR Biomed; 1990 Aug; 3(4):178-83. PubMed ID: 2206850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial heterogeneity of the metabolic response of RIF-1 tumors to a vasoactive agent evaluated in vivo by one-dimensional 31P chemical-shift imaging.
    Bhujwalla ZM; Blackband SJ; Wehrle JP; Glickson JD
    Magn Reson Med; 1992 Aug; 26(2):308-12. PubMed ID: 1513252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of anti-tumor effects of hyperthermia combined with hydralazine on experimental tumor].
    Aoki Y; Akagi K; Kitada N; Tanaka Y; Fritz-Zieroth B
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Nov; 55(14):987-92. PubMed ID: 8570396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of intratumor pH by pH indicator used in 19F-magnetic resonance spectroscopy. Measurement of extracellular pH decrease caused by hyperthermia combined with hydralazine.
    Aoki Y; Akagi K; Tanaka Y; Kawai J; Takahashi M
    Invest Radiol; 1996 Nov; 31(11):680-9. PubMed ID: 8915749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hydralazine-induced vasodilation on the energy metabolism of murine tumors studied by in vivo 31P-nuclear magnetic resonance spectroscopy.
    Okunieff P; Kallinowski F; Vaupel P; Neuringer LJ
    J Natl Cancer Inst; 1988 Jul; 80(10):745-50. PubMed ID: 3385782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel non-invasive probes for measuring tumor-hypoxia by 19F-magnetic resonance spectroscopy (19F-MRS). Studies in the SCCVII/C3H murine model.
    Papadopoulou MV; Pouremad R; Bloomer WD; Wyrwicz A
    Anticancer Res; 2006; 26(5A):3259-63. PubMed ID: 17094438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.